抗线粒体抗体相关炎性肌病:一种伴心脏受累的独特表型
该研究基于前瞻性肌炎队列,回顾性分析7例确诊抗线粒体抗体(AMA)相关炎性肌病患者,发现其多表现为慢性骨骼肌受累(平均6.5年乏力史),5/7(71%)存在心脏受累且常先于肌肉症状,提示AMA相关炎性肌病为一种独特表型,应早期识别并检测AMA。
要点
- AMA相关炎性肌病常呈慢性病程,平均6.5年乏力史,可伴肌萎缩及肩胛翼状肩。
- 心脏受累见于5/7(71%)患者,包括心肌炎、房室心律失常和心肌病,常先于肌肉症状。
- 肌活检可表现为免疫介导坏死性肌病、皮肌炎、多肌炎或非特异性/肉芽肿性肌炎。
核心结论
- 抗线粒体抗体(AMA)标识一种独特的炎性肌病表型,常与慢性骨骼肌病和严重心脏受累相关。
- 早期识别该罕见免疫介导实体对治疗决策具有重要意义。
- 建议对临床表现相符的患者检测AMA状态。
研究设计与样本
- 基于前瞻性肌炎队列,回顾性病历复习7例确诊AMA相关炎性肌病患者。
- 评估临床表现、实验室、影像、电生理及组织病理学特征。
主要发现
- 1例表现为皮肌炎,6例符合Bohan和Peter多肌炎标准。
- 除1例外均呈慢性肌肉受累病程,就诊前平均乏力6.5年;常伴肌萎缩,2例出现肩胛翼状肩。
- 肌活检示免疫介导坏死性肌病4例、皮肌炎1例、多肌炎1例、非特异性或肉芽肿性肌炎1例;2/7例见线粒体改变。
- 心脏受累(包括心肌炎、房性和室性心律失常、心肌病)见于5/7(71%)患者,通常先于肌肉受累。
- 3/7例合并其他自身免疫病,包括原发性胆汁性肝硬化、自身免疫性肝炎、银屑病和桥本甲状腺炎。
关键数值与推荐
- 心脏受累见于5/7(71%)的AMA相关炎性肌病患者。
- 就诊前平均乏力病程6.5年。
- 肌活检免疫介导坏死性肌病4例,皮肌炎1例,多肌炎1例,非特异性或肉芽肿性肌炎1例。
- 合并自身免疫病3/7例。
临床怎么用
- 对临床表现相符的炎性肌病患者应检测抗线粒体抗体(AMA)状态。
- AMA阳性炎性肌病患者需评估心脏受累,包括心肌炎、心律失常和心肌病。
- 识别AMA相关炎性肌病为免疫介导过程,有助于指导治疗决策。
局限性
- 回顾性病历复习,样本量仅7例。
- 来自单中心前瞻性肌炎队列,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: In the context of clinical evaluations performed on our prospective myositis cohort, we noted a striking association of severe cardiac disease in myositis patients with anti-mitochondrial antibodies. We sought to review all cases of anti-mitochondrial antibody (AMA) associated myositis in our cohort to describe the clinical features of this disease subset. METHODS: We identified 7 patients with confirmed anti-mitochondrial antibodies who presented as an inflammatory myopathy. A retrospective chart review was completed to assess their clinical presentation, laboratory, imaging, electrophysiologic, and histopathologic features. RESULTS: One patient presented with dermatomyositis and 6 were classified as polymyositis using Bohan and Peter criteria. In all but one patient, a chronic course of muscle involvement was appreciated with an average of 6.5 years of weakness prior to presentation. Muscle atrophy was often noted, as well as atypical findings of scapular winging in 2 of the patients. Muscle biopsies were consistent with immune-mediated necrotizing myopathy in 4 patients, dermatomyositis in 1, polymyositis in 1 and nonspecific or granulomatous myositis in 1 patient. Changes pointing to mitochondrial alterations were seen in 2 of the 7 patients. Cardiac involvement (including myocarditis, atrial and ventricular arrhythmias, and cardiomyopathy), was seen in 5 out of 7 (71%) of the patients, and usually preceded the muscle involvement. Coexisting autoimmune conditions were seen in 3/7of the patients and included primary biliary cirrhosis, autoimmune hepatitis, psoriasis, and Hashimoto's thyroiditis. CONCLUSIONS: Anti-mitochondrial antibodies identify a distinct inflammatory myopathy phenotype that is frequently associated with chronic skeletal muscle disease and severe cardiac involvement. Early recognition of this rare entity as an immune-mediated process is important due to implications for treatment. We propose that anti-mitochondrial antibody status should be determined in patients with a compatible clinical picture.
引用
- Albayda J, Khan A, Casciola-Rosen L, et al. Inflammatory myopathy associated with anti-mitochondrial antibodies: A distinct phenotype with cardiac involvement. Semin Arthritis Rheum. 2017. PMID: 28893408. doi:10.1016/j.semarthrit.2017.06.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。